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ABSTRACT
Objective: In national health insurance (JKN) era, pharmacy can play roles in the form of behind refer pharmacies, or networking pharmacy and clinic 
pharmacy pratama. Behind refer pharmacies drug cost can be claimed directly to BPJS, meanwhile for the other type of pharmacy have to negotiation 
first with the primary health care. Drug cost variations in the JKN era affect the profitability of the business pharmacies. This research aims to the drug 
percentage charges against capitation and variety of drug costs.
Methods: This research is analytic observational cross-sectional. This research uses secondary data from a JKN prescription patient. This research 
was conducted on 6 affiliated pharmacies, 6 networking pharmacies, and 7 clinical pharmacy pratama in DIY. The sampling in this research is by 
purposive with 8.430 prescriptions. Data drug costs JKN era was analyzed by descriptive statistics and comparative test (Kruskal Wallis test).
Results: The result showed that average percentage of drug costs for capitation fee in the networking pharmacy is 13.58% and primary health care 
is 15.91%. Pharmacy in JKN era has drug cost variations (p=0.000). Drug cost in JKN era depends on the pattern of play roles with the health facilities 
and BPJS. The average percentage of drug costs against capitation health facilities in networking pharmacy is lower than clinical pharmacy pratama.
Conclusions: Drug costs in an era of JKN depending on the pattern of cooperation with health facilities pharmacies and BPJS. The average percentage 
of the cost of drugs to the pharmacy capitation health facilities in networking lower than clinic pharmacy pratama. Differences in drug costs JKN era 
influenced by the long days of drug administration, the number of prescription sheets, margin.
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INTRODUCTION
Services national health insurance (JKN) implemented by doing a 
cooperation agreement between the Social Security Administrator 
(BPJS) and health facilities that exist throughout Indonesia, for health 
facilities who have no means of pharmacy can work together with the 
pharmacy in pharmacy services [2]. Pharmacy cooperation program 
with BPJS and family doctors are also supported by the regulation of 
health minister no. 71 years 2013 on Health Care in National Health 
Insurance in article 3 states that pharmacy services are as support 
services for health care services. Health facilities first level of BPJS earn 
rewards in the form of payment in the form of capitation rates with 
the specific amount to be transferred directly to the account of health 
facilities, capitation fee includes the cost of services and drugs [5].
Pharmacy services as support services should be taken into account 
in the capitation system, because pharmacists have an important role, 
especially in terms of adjustment of capitation fees to the cost of drugs 
adapted to the economic conditions of patients without neglecting the 
effects of therapy. The concept of the actual cost is by analyzing the 
resources used in producing a good or service [1]. In the era of JKN 
pharmacies can act as a pharmacy behind the reconciliation program 
(DRR) or the pharmacy network and clinical pharmacy pratama (KP). 
Areas that have been implementing the three types of the role of these 
pharmacies, one of the Special Region of Yogyakarta (DIY). A total 
number of pharmacies, family physicians, and clinics pratama that 
joint with BPJS in DIY in 2014 that became the Giver of Health Services 
(KDP) and the first level of health support services are as much as 12 
pharmacies PRB, 124 family physicians, 16 clinics pratama. In this case, 
only a few facilities that are directly related pharmacy health BPJS, 
which is only 12 pharmacies PRB (Lawrence, 2015).
Drug costs refer to the entire pharmacy program through a uniform 
that follows the price of drugs in the catalog plus a profit margin and 
factors pharmacy services in accordance with the Social Security Act. 
Pharmacy drug costs and pharmacy networks pratama clinic refers to 
an agreement made by pharmacists and health facilities. The cost of 
medicines included in the capitation fees earned each month from BPJS 
health facilities Health, but there are no clear rules related to margin 
and pharmacy services [2].
Pharmacies as cooperation with BPJS health support services and 
family doctor is a good momentum to enhance the role and welfare of 
pharmacists in Indonesia, which is able to collaborate in a comprehensive 
manner with a doctor and have a high bargaining power in the health 
system in Indonesia. The amount of drug costs varied greatly tangent 
to the profitability of the pharmacy and the pharmacist’s welfare. In 
this study, researchers wanted to know the percentage of the cost of 
drugs to the primary health facilities capitation, and the cost difference 
behind refers pharmacy, drugstore networks, and clinical pharmacy 
pratama DIY.
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METHODS
Research design
This research is observational analytic cross-sectional. This observation 
study uses secondary data JKN patient prescriptions.
Research instruments
The research material JKN patient prescriptions taken retrospectively 
in March 2015. The tools used in this research is a form created by 
the researchers based on the Regulation of the Minister of Health 
of the Republic of Indonesia Number 59 of 2014 About Standard 
rates Health Care and Health Insurance Program Implementation 
Guidebook practical Network First Level Health facilities (DPP) with 
a pharmacy.
Research subjects
Sampling was done by purposive sampling and was elected in March 
2015 with 8430 sheet JKN patient prescription drugs, as listed 
in Table 1. The selection of recipes March 2015 because after the 
preliminary study, it turns JKN patient prescription data is available and 
is the most complete in March 2015 in each pharmacy.
Data analysis
Analysis percentage against drug costs capitation system
The percentage of drug cost network pharmacies to family doctors 
capitation fee and percentage numbers of patient visits per month 
pharmacy network against family physician capitation obtained as 
follows:
(Total cost of drugs per month)/(cost per month family physicians 
capitation)×100%
Drug cost difference analysis era JKN
This study also conducted a comparative analysis of the cost of drugs in 
pharmacies PRB, pharmacy network, clinical pharmacy pratama using 
Kruskal–Wallis test and post-hoc test by Mann–Whitney.
RESULTS AND DISCUSSION
Analysis of the percentage of drug costs to the system of capitation
The cost of medicines in pharmacies and pharmacy network of pratama 
clinics included in the capitation fee family physicians and clinics 
pratama. The capitation system pays to the doctor or clinic pratama for 
services and the cost of drugs, so the cost of the drug to doctors and 
clinics pratama burden. Results of research conducted by Martiningsing, 
in 2009, obtained results that the high cost of drugs per patient on a 
capitation payment system is lower than the system of payment of fee 
for service [7].
Table 2 shows that the average percentage of the cost of drugs to the 
pharmacy network of family doctors capitation of 13.58%. Drug cost-
sharing in the cost of capitation health facilities not regulated clearly 
in the act so that the results of this study can be used as a reference 
for setting the distribution of drug costs in capitation fees earned 
health facilities. The number of sheets pharmacy prescriptions 
received in 1 month is directly proportional to the amount of the drug 
on the capitation fee. J06 has numbers pharmacy prescription sheet 
smallest among other pharmacies because these pharmacies serving 
patients from the dentist. The cost of medicines in the pharmacy 
network is limited by a cooperation agreement made by pharmacists 
and family doctors. The family doctor to reduce the cost of drugs the 
patient to reduce the burden of the cost, while the pharmacist wanted 
drug costs including profit margin and pharmacist services follow the 
policy established by the pharmacy. The entire pharmacy network 
that is used as a place of research (6 pharmacy network) only working 
with one family doctor, while the number of registered family doctor 
cooperate with BPJS Health in the province amounted to 124 family 
physicians. Pharmacies still has a high chance of becoming pharmacy 
networks collaborate more family doctors. In the capitation payment 
system, all health-care providers should recalculate the allocation 
of the cost of services and the cost of medications, thus improving 
the quality of service. One study conducted by the Division of Health 
Services Research and Policy, University of Minnesota also has 
proved that this method of financing health-care provider influence 
behavior [3].
Table 1: Number of samples cost drug research of national 
Health insurance era (sheet recipe)
Pharmacy type Number of pharmacy Number of 
prescription
Networking pharmacy 7 1966
Clinical pharmacy pratama 7 4870
Behind refer pharmacy 6 1594
Total 8430
Table 2: Cost drugs and figures percentage patient visits per month against capitation family physicians pharmacy networking In DIY
Code Capitation family 
physicians (persons)
Capitation fee (Rp) Number of prescribe (n) Total cost of drugs 
per month (USD)
Capitation fees against drugs (%)
J01 1012 10.120.000 36 477.500 4.72
J02 5579 55.790.000 338 3.890.100 6.97
J03 3751 37.510.000 1189 16.298.146 43.45
J04 3417 34.170.000 214 5.661.700 16.57
J05 3317 33.170.000 172 2.805.000 8.46
J06 6938 13.876.000 15 184.500 1.33
Average 13.58
Table 3: Cost drugs and figures percentage patient visits per month against capitation system clinic primary In DIY
Code Clinic capitation (persons) Capitation cost (Rp) Number of 
prescriptions (n)
Total drug cost per month (Rp) Drug cost against 
capitation (%)
KP01 3858 46.296.000 778 11.670.000 25.21
KP02 2243 26.916.000 255 3.841.065 14.27
KP03 4929 59.148.000 1044 15.660.000 26.48
KP04 8142 97.704.000 296 4.440.000 4.54
KP05 653  7.836.000 60 718.603 9.17
KP06 10264 123.168.000 1252 15.615.000 12.68
KP07 7448 89.376.000 1062 17.028.250 19.05
Average 15.91
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Table 3 shows that the average percentage of the cost of drugs to the 
clinic capitation pratama in clinical pharmacy pratama worth 15.91%, 
meaning that this value is greater than the pharmacy network. Pratama 
clinical pharmacy drug costs are relatively more flexible than the 
pharmacy network because the pharmacy and health facilities have 
one management managers and capitation fees earned clinic pratama 
greater than capitation fees earned family doctor. Pratama clinic 
can manage and set policy for its own pharmacy. Pharmacists at the 
clinic pratama can be employees who receive a fixed salary or contract 
employees pratama clinic. Insurers can better control the availability 
of drugs and drug price changes, so the service is faster and more 
efficient [9].
Comparative analysis of drug costs
The table 4 shows the comparation of drug cost   in pharmacies era JKN. 
The results of comparison test drug costs have p<0.005, meaning that 
at least there is a difference in drug costs for patients once treatment 
between the two types of pharmacies and statistically significant value 
(p=0.000). Post-hoc test with Mann–Whitney test to determine the type 
of pharmacy obtained results behind refer Pharmacy (PRB) versus 
networking pharmacy, networking pharmacy versus clinics pharmacy 
pratama, behind refer pharmacies (PRB) versus clinical pharmacy 
pratama worth p=0.000.
Differences in drug costs in three types depending on the pattern 
pharmacies owned by pharmacy good cooperation with health and 
health facilities BPJS primary, factors affecting the cost of drugs in JKN 
era is long days of drug administration, the number of prescriptions, 
profit margins, and pharmacy services.
Long days of drug administration
Pharmacies networks and clinic pharmacy pratama has average long 
days of drug administration for 3-5 days, while the average behind 
refers pharmacy (PRB) old days of drug administration for 30 days. 
The results of research supported by research conducted by Isnaini 
who conducts research on primary health facilities on utilization 
analysis outpatient antibiotic prescriptions first level (RJTK) in Tebet 
Puskesmas in 2005 showed that the average length of antibiotic drug 
delivery days 3.96 days or rounded to 4 days [4] (Isnaini, 2007).
Total prescriptions
Pharmacy networks research sample (n=6) only in cooperation with 
the family doctor, while the family doctor who recorded in the province 
amounted to 124 doctors, so the recipes that netted less than clinical 
pharmacy pratama. Prescription the system can facilitate patient’s 
pharmacy network to obtain prescription drugs, but bona fide high 
administrative costs for the family doctor. Drug costs borne by the family 
doctor so that not all patients netted prescription in pharmacies [9].
The profit margin
The profit margin pharmacies and pharmacy network of clinics pratama 
by 20-30%, while the profit margin of pharmacies PRB joined by a 
factor of pharmaceutical services specified by the Minister of Health 
Regulation No. 59 of 2014 on the Standard Rates of Health Services 
in the Implementation of Health Insurance Program. In 1994 in some 
American states (Idaho, New York, Pennsylvania, Rhode Island, and 
West Virginia) had a profit margin of prescription drugs by 16%, while 
in Florida only has a profit margin of 3.6% [8].
Pharmacy services
Pharmacies service in networks varies widely established in accordance 
with pharmacy policy and agreement with the family doctor. Services 
pharmacy services per item lowest highest worth Rp 200 and Rp 2,000 
worth. Pharmacies service in the PRB has been determined by factors 
indicative price multiplied by the pharmacy services in accordance drugs 
e-catalogue [6] (Ministry of Health, 2014). Each state in America has its 
own rules for reimbursement of drug costs, for dispensing services and 
profit margins vary widely. For example, in 1994 a very low dispensing 
services in southern Virginia is US $ 2.75, while in Maryland and Alaska 
have consecutive dispensing services of US $ 6.18 and US $ 7.45 [8].
CONCLUSION
Drug costs in an era of JKN depending on the pattern of cooperation 
with health facilities pharmacies and BPJS. The average percentage 
of the cost of drugs to the pharmacy capitation health facilities in 
networking lower than clinic pharmacy pratama. Differences in drug 
cost JKN era influenced by the long days of drug administration, the 
number of prescription sheets and margin.
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Table 4: Comparative cost analysis of drugs in pharmacies era JKN
Pharmacy group n Mean±SD P value cost drugs p value







Pharmacy network versus clinical pharmacy pratama P<0.005; pharmacy 
network versus behind refer pharmacies P<0.005, clinic pharmacy pratama 
versus behind refer pharmacy P<0.005
